The H6D genetic variation of GDF15 is associated with genesis, progress and prognosis in colorectal cancer
- 1 November 2015
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 211 (11) , 845-850
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81090421, 81171938, 81201557)
- Zhejiang Provincial Natural Science Foundation of China (LY15H160067, LY15H160032))
This publication has 39 references indexed in Scilit:
- Cancer treatment and survivorship statistics, 2012CA: A Cancer Journal for Clinicians, 2012
- Identification of Serum Biomarkers for Colorectal Cancer Metastasis Using a Differential Secretome ApproachJournal of Proteome Research, 2009
- Survival Following Recurrence in Stage II and III Colon Cancer: Findings From the ACCENT Data SetJournal of Clinical Oncology, 2008
- Cancer Metastasis: Building a FrameworkCell, 2006
- Identification of Nonsteroidal Anti-inflammatory Drug-activated Gene (NAG-1) as a Novel Downstream Target of Phosphatidylinositol 3-Kinase/AKT/GSK-3β PathwayJournal of Biological Chemistry, 2004
- Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cellsCarcinogenesis, 2004
- Nonsteroidal anti‐inflammatory drug‐activated gene (NAG‐1) is induced by genistein through the expression of p53 in colorectal cancer cellsInternational Journal of Cancer, 2003
- Diallyl Disulfide (DADS) Induces the Antitumorigenic NSAID-Activated Gene (NAG-1) by a p53-Dependent Mechanism in Human Colorectal HCT 116 CellsThe Journal of Nutrition, 2002
- Cyclooxygenase Inhibitors Regulate the Expression of a TGF-β Superfamily Member That Has Proapoptotic and Antitumorigenic ActivitiesMolecular Pharmacology, 2001
- Cancer risk in patients with inflammatory bowel diseaseCancer, 2001